bioXXmed AG T5O.DE Stock
bioXXmed AG Price Chart
bioXXmed AG T5O.DE Financial and Trading Overview
bioXXmed AG stock price | 0.56 EUR |
Previous Close | 1.9 EUR |
Open | 1.9 EUR |
Bid | 1.84 EUR x 25600 |
Ask | 1.9 EUR x 140000 |
Day's Range | 1.87 - 1.9 EUR |
52 Week Range | 1.1 - 3.65 EUR |
Volume | 3.04K EUR |
Avg. Volume | 828 EUR |
Market Cap | 9.61M EUR |
Beta (5Y Monthly) | 1.476245 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.13 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 34.85 EUR |
T5O.DE Valuation Measures
Enterprise Value | 6.08M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 215.99239 |
Price/Book (mrq) | 0.44135 |
Enterprise Value/Revenue | 136.797 |
Enterprise Value/EBITDA | -4.327 |
Trading Information
bioXXmed AG Stock Price History
Beta (5Y Monthly) | 1.476245 |
52-Week Change | -44.92% |
S&P500 52-Week Change | 20.43% |
52 Week High | 3.65 EUR |
52 Week Low | 1.1 EUR |
50-Day Moving Average | 2.23 EUR |
200-Day Moving Average | 2.13 EUR |
T5O.DE Share Statistics
Avg. Volume (3 month) | 828 EUR |
Avg. Daily Volume (10-Days) | 771 EUR |
Shares Outstanding | 5.14M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0.11% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | June 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -3190.31% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -4.037% |
Return on Equity (ttm) | -18.27% |
Income Statement
Revenue (ttm) | 44.48K EUR |
Revenue Per Share (ttm) | 0.009 EUR |
Quarterly Revenue Growth (yoy) | -3.40% |
Gross Profit (ttm) | 44.63K EUR |
EBITDA | -1406322 EUR |
Net Income Avi to Common (ttm) | -3937847 EUR |
Diluted EPS (ttm) | -0.9 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 4.1M EUR |
Total Cash Per Share (mrq) | 0.8 EUR |
Total Debt (mrq) | 418.88K EUR |
Total Debt/Equity (mrq) | 1.92 EUR |
Current Ratio (mrq) | 29.853 |
Book Value Per Share (mrq) | 4.237 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of bioXXmed AG
Country | Germany |
State | N/A |
City | Darmstadt |
Address | N/A |
ZIP | 64295 |
Phone | N/A |
Website | https://cytotools.de |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. The company was founded in 2000 and is based in Darmstadt, Germany.
Q&A For bioXXmed AG Stock
What is a current T5O.DE stock price?
bioXXmed AG T5O.DE stock price today per share is 0.56 EUR.
How to purchase bioXXmed AG stock?
You can buy T5O.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for bioXXmed AG?
The stock symbol or ticker of bioXXmed AG is T5O.DE.
Which industry does the bioXXmed AG company belong to?
The bioXXmed AG industry is Biotechnology.
How many shares does bioXXmed AG have in circulation?
The max supply of bioXXmed AG shares is 5.14M.
What is bioXXmed AG Price to Earnings Ratio (PE Ratio)?
bioXXmed AG PE Ratio is now.
What was bioXXmed AG earnings per share over the trailing 12 months (TTM)?
bioXXmed AG EPS is -0.13 EUR over the trailing 12 months.
Which sector does the bioXXmed AG company belong to?
The bioXXmed AG sector is Healthcare.